The health expenditure in India has shown a gradual increase from 4.53% of GDP in 2013 to 4.92% in 2023, with a year-on-year growth rate of approximately 0.6% in recent years. The Compound Annual Growth Rate (CAGR) has been declining, reflecting lower incremental growth, culminating in a CAGR of 0.63% over the past five years.
The forecast indicates a continued but modest growth in health expenditure, reaching 5.06% of GDP by 2028. The forecasted average annual growth (CAGR) over the next five years is expected to be around 0.44%, suggesting a slower growth trajectory compared to previous years.
Future trends to watch for include:
- Impact of government policies targeted at increasing healthcare funding.
- How economic fluctuations influence healthcare spending.
- Technological innovations and their role in cost management.
- Initiatives to expand healthcare access in rural areas.
- The effect of demographic changes, particularly an aging population, on healthcare demand.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...